SOPH SOPHiA GENETICS, Inc.
SOPHiA GENETICS, Inc. (SOPH) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $89.1K.
Where they traded
Last open-market purchase: June 5, 2026 , by CARDOZA GEORGE .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| HIBBS KATHY L | Director | Sell 10b5-1 | 6,250 | $8.13 | $50.8K | 96,992 −6.1% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 10,000 | $8.91 | $89.1K | 556,887 −1.8% of holding | |
| HIBBS KATHY L | Director | Sell 10b5-1 | 6,250 | $8.68 | $54.2K | 103,242 −5.7% of holding | |
| Menu Philippe | Chief Medical Officer | Sell 10b5-1 | 5,000 | $8.68 | $43.4K | 213,387 −2.3% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $8.80 | $44.0K | 172,171 −2.8% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 5,408 | $8.40 | $45.4K | 566,887 −0.9% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,592 | $8.41 | $38.6K | 572,295 −0.8% of holding | |
| Valente Manuela | Chief People Officer | Sell 10b5-1 | 10,000 | $7.94 | $79.4K | 210,450 −4.5% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 10,000 | $7.94 | $79.4K | 576,887 −1.7% of holding | |
| Verma Abhimanyu | Chief Technology Officer | Sell 10b5-1 | 5,000 | $8.20 | $41.0K | 177,171 −2.7% of holding | |
| Xu Zhenyu | Chief Scientific Officer | Sell 10b5-1 | 4,000 | $7.52 | $30.1K | 586,887 −0.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.